SF Rowasa
SF Rowasa (sulfite-free mesalamine) rectal suspension is an aminosalicylate anti-inflammatory drug. It is administered rectally to treat active mild to moderate distal ulcerative colitis, proctosigmoiditis, or proctitis. It works locally in the lower intestine and colon to reduce inflammation and associated symptoms.
Dosage by Body Weight
The usual adult dose of SF Rowasa rectal suspension is one rectal instillation (4 g in 60 mL) once a day, preferably at bedtime, retained for approximately 8 hours. Shake the bottle well before use. Safety and efficacy in pediatric patients have not been established.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Use only if prescribed | Safety and effectiveness in pediatric patients have not been established. |
| 5-7 kg | Not routine | Use only if prescribed | Safety and effectiveness in pediatric patients have not been established. |
| 8-10 kg | Not routine | Use only if prescribed | Safety and effectiveness in pediatric patients have not been established. |
| 11-15 kg | Not routine | Use only if prescribed | Safety and effectiveness in pediatric patients have not been established. |
| 16-20 kg | Not routine | Use only if prescribed | Safety and effectiveness in pediatric patients have not been established. |
Formulation
Purpose
Treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis, or proctitis.
Generic Name
MesalamineScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.